Worth Watching Stocks Inovio Pharmaceuticals, Inc.(NASDAQ:INO): Hudson Technologies, Inc.(NASDAQ:HDSN)

0
4

Inovio Pharmaceuticals, Inc. (INO) will report its next earnings on Nov 08 AMC. The company reported the earnings of $-0.27/Share in the last quarter where the estimated EPS by analysts was $-0.3/share. The difference between the expected and actual EPS was $0.03/share, which represents an Earnings surprise of 10%.

Many analysts are providing their Estimated Earnings analysis for Inovio Pharmaceuticals, Inc. and for the current quarter 6 analysts have projected that the stock could give an Average Earnings estimate of $-0.27/share. These analysts have also projected a Low Estimate of $-0.3/share and a High Estimate of $-0.14/share.

In case of Revenue Estimates, 5 analysts have provided their consensus Average Revenue Estimates for Inovio Pharmaceuticals, Inc. as 5.6 Million. According to these analysts, the Low Revenue Estimate for Inovio Pharmaceuticals, Inc. is 1.05 Million and the High Revenue Estimate is 18.4 Million. The company had Year Ago Sales of 8.79 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for INO to be -25%. They are projecting Next Quarter growth of 16.67%. For the next 5 years, Inovio Pharmaceuticals, Inc. is expecting Growth of -6% per annum, whereas in the past 5 years the growth was 8.26% per annum.

Some buy side analysts are also providing their Analysis on Inovio Pharmaceuticals, Inc., where 3 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Inovio Pharmaceuticals, Inc. might touch $13 high while the Average Price Target and Low price Target is $10.8 and $8 respectively.

Inovio Pharmaceuticals, Inc. closed its last trading session at $5.22 with the gain of 0%. The Market Capitalization of the company stands at 497.73 Million. The Company has 52-week high of $6.30 and 52-week low of $3.64. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 1.14% where SMA50 and SMA200 are -0.58% and 9.79% respectively. The Company Touched its 52-Week High on 10/02/18 and 52-Week Low on 06/28/18.

The Relative Volume of the company is 0.71 and Average Volume (3 months) is 1 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 0.

The company shows its Return on Assets (ROA) value of -52.6%. The Return on Equity (ROE) value stands at -72.7%. While it’s Return on Investment (ROI) value is -58.7%.

While looking at the Stock’s Performance, Inovio Pharmaceuticals, Inc. currently shows a Weekly Performance of -0.76%, where Monthly Performance is 1.36%, Quarterly performance is -5.78%, 6 Months performance is 14.73% and yearly performance percentage is 16.26%. Year to Date performance value (YTD perf) value is 26.39%. The Stock currently has a Weekly Volatility of 3.43% and Monthly Volatility of 4.64%.

Many analysts are providing their Estimated Earnings analysis for Hudson Technologies, Inc. and for the current quarter 0 analysts have projected that the stock could give an Average Earnings estimate of $0/share. These analysts have also projected a Low Estimate of $0/share and a High Estimate of $0/share.

In case of Revenue Estimates, 3 analysts have provided their consensus Average Revenue Estimates for Hudson Technologies, Inc. as 31.28 Million. According to these analysts, the Low Revenue Estimate for Hudson Technologies, Inc. is 21.5 Million and the High Revenue Estimate is 37.34 Million. The company had Year Ago Sales of 24.61 Million.

These analysts also forecasted Growth Estimates for the Current Quarter for HDSN to be 240%. They are projecting Next Quarter growth of -133.33%. For the next 5 years, Hudson Technologies, Inc. is expecting Growth of 169.35% per annum, whereas in the past 5 years the growth was -165.96% per annum.

Some buy side analysts are also providing their Analysis on Hudson Technologies, Inc., where 1 analysts have rated the stock as Strong buy, 0 analysts have given a Buy signal, 0 said it’s a HOLD, and 0 analysts rated the stock as Sell. (These Recommendations are for the Current Month Only reported by Yahoo Finance.)

When it comes to the Analysis of a Stock, Price Target plays a vital role. Analysts reported that the Price Target for Hudson Technologies, Inc. might touch $4 high while the Average Price Target and Low price Target is $4 and $4 respectively.

Hudson Technologies, Inc. closed its last trading session at $1.71 with the gain of 0%. The Market Capitalization of the company stands at 71.85 Million. The Company has 52-week high of $6.98 and 52-week low of $0.70. The stock’s current distance from 20-Day Simple Moving Average (SMA20) is 50.15% where SMA50 and SMA200 are 58.96% and -33.75% respectively. The Company Touched its 52-Week High on 01/25/18 and 52-Week Low on 11/12/18.

The Relative Volume of the company is 2.58 and Average Volume (3 months) is 533.89 million. The company’s P/E (price to earnings) ratio is 0 and Forward P/E ratio of 8.03.

The company shows its Return on Assets (ROA) value of 0%. The Return on Equity (ROE) value stands at 0%. While it’s Return on Investment (ROI) value is 4.4%.

While looking at the Stock’s Performance, Hudson Technologies, Inc. currently shows a Weekly Performance of 58.33%, where Monthly Performance is 67.65%, Quarterly performance is -7.07%, 6 Months performance is -27.54% and yearly performance percentage is -69.57%. Year to Date performance value (YTD perf) value is -71.83%. The Stock currently has a Weekly Volatility of 19.72% and Monthly Volatility of 17.60%.

SHARE